IMM-004

N/A

Report date: 2025/02/17 16:02:11
NME

Base Information

Drug NameIMM-004
Drug Alias NameIMM-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBTB domain and CNC homolog 1 inhibitors
TargetsBTB domain and CNC homolog 1
Therapy Area/Indicationsbeta-ThalassemiaAnemia, Sickle CellRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIMMvention Therapeutix Inc
China Registration ClassN/A

Develop Information

Active CompaniesIMMvention Therapeutix IncNovo Nordisk A/S
Inactive CompaniesN/A
Active Indicationsbeta-ThalassemiaAnemia, Sickle CellRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A